CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (OP) - USD ($) $ in Thousands | 3 Months Ended |
Mar. 31, 2023 | Mar. 31, 2022 |
Net income | $ 112,246 | $ 79,506 |
Depreciation, Depletion and Amortization | 87,741 | 84,222 |
Amortization of Debt Discount (Premium) | (716) | (716) |
Deferred financing cost amortization | 1,755 | 1,766 |
Accretion of above- and below-market leases, net | (3,389) | (2,971) |
Tenant inducement amortization and other | 804 | 1,048 |
Impairment of Real Estate | 1,100 | 4,590 |
Gain on sale | (48,468) | (21,911) |
Equity based compensation | 4,191 | 4,315 |
Increase (Decrease) in Accounts and Other Receivables | 15,578 | (4,682) |
Deferred charges and prepaid expenses | (11,815) | (8,605) |
Other assets | (215) | (180) |
Increase Decrease In Other Liabilities And Due To Related Parties | (23,758) | (24,122) |
Net cash provided by operating activities | 135,054 | 112,260 |
Payments to Develop Real Estate Assets | (72,376) | (70,121) |
Acquisitions of real estate assets | 0 | (164,262) |
Proceeds from sales of real estate assets | 119,659 | 58,870 |
Payments to Acquire Marketable Securities | (6,162) | (8,844) |
Proceeds from sale of marketable securities | 7,364 | 9,420 |
Net cash provided by (used in) investing activities | 48,485 | (174,937) |
Repayment of borrowings under unsecured revolving credit facility | (195,000) | (115,000) |
Proceeds from borrowings under unsecured revolving credit facility | 117,000 | 210,000 |
Repayment of borrowings under unsecured term loans and notes | 0 | (250,000) |
Payments of Financing Costs | (60) | 0 |
Proceeds from issuances of common shares | 0 | 43,871 |
Net cash used in financing activities | (169,369) | (194,682) |
Net change in cash, cash equivalents and restricted cash | 14,170 | (257,359) |
Cash, cash equivalents and restricted cash at end of period | 35,429 | 40,384 |
Cash and cash equivalents | 3,430 | 31,567 |
Restricted cash | 31,999 | 8,817 |
Supplemental Financial Information [Line Items] | | |
Cash and cash equivalents | 3,430 | 31,567 |
Restricted cash | 31,999 | 8,817 |
Cash, cash equivalents and restricted cash at end of period | 35,429 | 40,384 |
Cash paid for interest, net of amount capitalized of $949 and $677 | 50,250 | 48,491 |
Brixmor Operating Partnership LP | | |
Net income | 112,246 | 79,506 |
Depreciation, Depletion and Amortization | 87,741 | 84,222 |
Amortization of Debt Discount (Premium) | (716) | (716) |
Deferred financing cost amortization | 1,755 | 1,766 |
Accretion of above- and below-market leases, net | (3,389) | (2,971) |
Tenant inducement amortization and other | 804 | 1,048 |
Impairment of Real Estate | 1,100 | 4,590 |
Gain on sale | (48,468) | (21,911) |
Equity based compensation | 4,191 | 4,315 |
Increase (Decrease) in Accounts and Other Receivables | 15,578 | (4,682) |
Deferred charges and prepaid expenses | (11,815) | (8,605) |
Other assets | (215) | (180) |
Increase Decrease In Other Liabilities And Due To Related Parties | (23,758) | (24,122) |
Net cash provided by operating activities | 135,054 | 112,260 |
Payments to Develop Real Estate Assets | (72,376) | (70,121) |
Acquisitions of real estate assets | 0 | (164,262) |
Proceeds from sales of real estate assets | 119,659 | 58,870 |
Payments to Acquire Marketable Securities | (6,162) | (8,844) |
Proceeds from sale of marketable securities | 7,364 | 9,420 |
Net cash provided by (used in) investing activities | 48,485 | (174,937) |
Repayment of borrowings under unsecured revolving credit facility | (195,000) | (115,000) |
Proceeds from borrowings under unsecured revolving credit facility | 117,000 | 210,000 |
Repayment of borrowings under unsecured term loans and notes | 0 | (250,000) |
Payments of Financing Costs | (60) | 0 |
Proceeds from issuances of common shares | 0 | 43,871 |
Partner distributions and repurchases of OP Units | (90,382) | (74,923) |
Net cash used in financing activities | (168,442) | (186,052) |
Net change in cash, cash equivalents and restricted cash | 15,097 | (248,729) |
Cash, cash equivalents and restricted cash at end of period | 35,429 | 33,856 |
Cash and cash equivalents | 3,430 | 25,039 |
Restricted cash | 31,999 | 8,817 |
Supplemental Financial Information [Line Items] | | |
Cash and cash equivalents | 3,430 | 25,039 |
Restricted cash | 31,999 | 8,817 |
Cash, cash equivalents and restricted cash at end of period | 35,429 | 33,856 |
Cash paid for interest, net of amount capitalized of $949 and $677 | $ 50,250 | $ 48,491 |